MELAS syndrome as a cause of status epilepticus in children: Report on two brothers’ case in Peru.
DOI:
https://doi.org/10.20453/rnp.v85i4.4373Keywords:
MELAS syndrome, epileptic seizures, status epilepticus, hyperlactatemia, PeruAbstract
MELAS Syndrome is a mitochondrial disease associated with epileptic seizures. The case of two siblings with genetically confirmed MELAS is presented, with a history of recurrent status epilepticus accompanied by neurological deficits, failure to thrive, hyperlacticaemia, and brain lesions resembling strokes. The neurological presentation with epileptic status is highlighted to be considered in the corresponding differential diagnosis in emergency rooms and pediatric hospitals.
References
Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16(4):481-8. (Citado el 30 de mayo del 2022) Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ana.410160409
Goto Y, Nonaka I, Horai S. A mutation in the TRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990;348(6302):651-3. (Citado el 30 de mayo del 2022) Disponible en: https://www.nature.com/articles/348651a0
Manwaring N, Jones MM, Wang JJ, Rochtchina E, Howard C, Mitchell P, Sue CM. Population prevalence of the MELAS A3243G mutation. Mitochondrion. 2007;7(3):230-3. (Citado el 30 de mayo del 2022) Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1567724907000037?via%3Dihub
Uusimaa J, Moilanen JS, Vainionpaa L. Prevalence, Segregation, and Phenotype of the Mitochondrial DNA 3243A>G Mutation in Children. Annals of Neurology. 2007; 62(3). (Citado el 30 de mayo del 2022) Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/ana.21196
Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, et al. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. 2012;1820(5):619-24. (Citado el 30 de mayo del 2022) Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S030441651100064X?via%3Dihub . doi: 10.1016/j.bbagen.2011.03.015.
Aguirre-Quispe W, Valdez-Taboada M, Urbina-Ramírez L, Rivera-Valdivia A, Sarapura-Castro E, Montoya J, et al . Enfermedad de MELAS en Latinoamérica: revisión temática. Rev Neuropsiquiatr. 2021; 10: 316-332. (Citado el 30 de mayo del 2022) Disponible en: https://revistas.upch.edu.pe/index.php/RNP/article/view/4137 . doi: http://dx.doi.org/10.20453/rnp.v84i4.4137.
Rodríguez-Violante M, Cervantes-Arriaga A, Vargas-Cañas S. Papel de la función mitocondrial en las enfermedades neurodegenerativas. Arch Neurocien (Mex). 2010; 15(1).
Kraya T, Neumann L, Paelecke-Habermann Y, et al. Cognitive impairment, clinical severity and MRI changes in MELAS syndrome. Mitochondrion. 2019;44:53-57. doi: 10.1016/j.mito.2017.12.012
Chial H, Craig J. mtDNA and Mitochondrial Diseases. Nature Education. 2008; 1 (1) :217. (Citado el 30 de mayo del 2022) Disponible en: https://www.nature.com/scitable/topicpage/mtdna-and-mitochondrial-diseases-903/
Deng J, Lu Y, Xie Z, Liu J, Yuan Y, Wang Z. RNA-seq profiling, and impaired autophagic process in skeletal muscle of MELAS. Biochem Biophys Res Commun. 2020;523(1):91-97. doi: 10.1016/j.bbrc.2019.12.005
Tetsuka S, Ogawa T, Hashimoto R, Kato H. Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS. Metab Brain Dis. 2021 Dec;36(8):2181-2193. doi: 10.1007/s11011-021-00772-x.
Alston CL, Rocha MC, Lax NZ, Turnbull DM, Taylor RW. The genetics and pathology of mitochondrial disease. J Pathol. 2017;241(2):236-250. doi: 10.1002/path.4809.
Pia S, Lui F. Melas Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. Citado el 5 de junio del 2022) Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK532959/
Kraya T, Neumann L, Paelecke-Habermann Y, Deschauer M, Stoevesandt D, Zierz S, Watzke S. Cognitive impairment, clinical severity and MRI changes in MELAS syndrome. Mitochondrion. 2019;44:53-57. doi: 10.1016/j.mito.2017.12.012.
Bhatia, K. D., Krishnan, P., Kortman, H., Klostranec, J., & Krings, T. (2020). Acute Cortical Lesions in MELAS Syndrome: Anatomic Distribution, Symmetry, and Evolution. AJNR. 41(1), 167–173. https://doi.org/10.3174/ajnr.A6325
Cheng W, Zhang Y, He L. MRI Features of Stroke-Like Episodes in Mitochondrial Encephalomyopathy With Lactic Acidosis and Stroke-Like Episodes. Front Neurol. 2022 Feb 9;13:843386. doi: 10.3389/fneur.2022.843386.
Kim JH, Lim MK, Jeon TY, Rha JH, Eo H, Yoo SY, Shu CH. Diffusion and Perfusion Characteristics of MELAS (Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episode) in Thirteen Patients. Korean J Radiol. 2011 Jan-Feb;12(1):15-24. https://doi.org/10.3348/kjr.2011.12.1.15.
Lin, CM., Thajeb, P. Valproic Acid Aggravates Epilepsy due to MELAS in a Patient with an A3243G Mutation of Mitochondrial DNA. Metab Brain Dis 22, 105–109 (2007). https://doi.org/10.1007/s11011-006-9039-9
Lerma-Usabiaga G, Carreiras M, Paz-Alonso PM. Converging evidence for functional and structural segregation within the left ventral occipitotemporal cortex in reading. Proc Natl Acad Sci U S A. 2018;115(42):E9981-E9990. (Citado el 30 de mayo del 2022) Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196482/ .doi: 10.1073/pnas.1803003115.
Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol. 1994;9(1):4-13. doi: 10.1177/088307389400900102.
RNP is distributed under a 